QUEBEC, Jan. 7 /CNW Telbec/ - Victhom Human Bionics Inc., "Victhom" (TSX:
VHB), announced today that it will participate in the OneMedPlace Finance
Forum in San Francisco, CA on January 13 and 14, 2009. Nader Kameli, Chief
Operating Officer of Victhom's Neurobionix division, will be presenting on
Tuesday, January 13 at 9:00 a.m. Pacific Time, at the Sir Francis Drake Hotel
at 450 Powell Street. Information about the OneMedPlace Finance Forum may be
found at http://www.onemedplace.com.
Victhom has developed the Neurostep(R) System, an implantable
neurostimulation device designed to restore mobility and independence for
patients with partial paralysis of the leg as a result of hemiparetic stroke.
The Neurostep(R) System has been engineered to integrate with the body's
natural sensing and stimulation network and designed to closely mimic specific
functions that have been interrupted or lost due to disease or injury. The
Neurostep(R) is an investigational medical device currently in human clinical
study in four clinical sites outside U.S. and is planned for market
introduction in Europe late 2009.
Victhom discovers, develops and manufactures bionic devices involved in
the treatment of a variety of physical and physiological dysfunctions.
Victhom's Neurobionix division focuses on the development and
commercialization of technologies and products involving implantable devices
that feature neurosensing and neurostimulation components, integrated with
artificial intelligence. Victhom's Biotronix division develops biomechatronic
products to support or replace peripheral limbs in what is known as the
orthotics and prosthetics market.
OneMedPlace is a virtual community of healthcare and life science
companies. It has, for the first time, put in place the innovations that will
shape the future of health and medicine emerging companies and technologies
seeking capital, distribution, visibility and resources to help finance, build
and grow, and investors and strategic partners looking for health and medical
innovations to invest in, acquire, license, distribute, purchase or utilize.
Some of the statements made herein may constitute forward-looking
statements. These statements relate to future events or our future financial
performance and involve known and unknown risks, uncertainties and other
factors that may cause Victhom's actual results, performance or achievements
to be materially different from those expressed or implied by any of Victhom's
statements. Actual events or results may differ materially. We disclaim any
intention, and assume no obligation, to update these forward-looking
For further information:
For further information: Normand Rivard, Acting President & CFO, Victhom
Human Bionics Inc., (418) 872-5665, Fax: (418) 872-6926,
email@example.com, www.victhom.com; Sources: Victhom Human Bionics